|
인쇄하기
취소
|
GCC markets pioglitazone tablets
Published: 2008-08-20 06:59:00
Updated: 2008-08-20 06:59:00
Green Cross Corp. has launched Glulis (pioglitazone) tablets with an aim to strengthen its diabetic sector in addition to glimepiride and metformin.
Pioglitazone is a prescription drug of the class thiazolidinedione with hypoglycemic action. It is used for the treatment of diabetes mellitus type 2 in monotherapy but usually in combination with sulfonylurea, metformin, or insulin. Pioglitazon...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.